Related Experiment Videos
Letter: Allergic reactions to cis platinum
Lancet (London, England)
|January 10, 1976
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).
Cancer chemotherapy and pharmacology·2014
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.
European journal of cancer (Oxford, England : 1990)·2012
Telomerase and telomere inhibitors in preclinical development.
Expert opinion on investigational drugs·2005
Bridging Mechanisms and Strategies: MXene-Based Electrocatalysts for the Oxygen Evolution Reaction.
Nanomaterials (Basel, Switzerland)·2026
PLPPR3 and the making of neuronal filopodia.
Biological chemistry·2026
Hydroxylation Regulated Polar Interfaces for Enhanced Contact-Electro-Catalysis.
Advanced materials (Deerfield Beach, Fla.)·2026